XML 82 R57.htm IDEA: XBRL DOCUMENT v3.24.1
Collaboration and License Agreements and Acquisition - Collaboration Agreements - Additional Information (Detail) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Nov. 30, 2021
Jan. 31, 2018
Mar. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Research and Development Arrangements with Federal Government [Line Items]            
Loss on equity method investment       $ 7,549 $ 12,107 $ 803
Other (expense) income, net (including amounts with related parties)     $ 5,789 (221,642) (65,988) (19,559)
Amyris Joint Venture            
Research and Development Arrangements with Federal Government [Line Items]            
Advances to support operations       $ 0   1,000
Percentage of ownership interest       50.00%    
Loss on equity method investment       $ 7,500 12,100 800
Other (expense) income, net (including amounts with related parties)       (7,500) (11,900)  
Amyris Joint Venture | Amyris, Inc.            
Research and Development Arrangements with Federal Government [Line Items]            
Advances to support operations           1,000
National Cancer Institute (NCI) | 2015 CRADA            
Research and Development Arrangements with Federal Government [Line Items]            
Annual payment for support of research activities   $ 600        
National Cancer Institute (NCI) | 2015 CRADA | Research and development            
Research and Development Arrangements with Federal Government [Line Items]            
Payment for support of research activities       $ 1,300 $ 1,200 $ 1,100
National Cancer Institute (NCI) | 2015 CRADA, Amendment            
Research and Development Arrangements with Federal Government [Line Items]            
Annual project funding amount $ 1,300